Title Credit Typesort descending Event date Cost
Following a Moving Target: Advances in PSMA Radioligand Therapy for Prostate Cancer
    • 0.75 AMA PRA Category 1 Credit™
    • 0.75 ANCC
    • 0.75 ACPE Pharmacy
    • 0.75 AAPA Category I CME
    • 0.75 Attendance
 Enduring $0.00

Pages